Close

Janssen-Cilag Receives Positive CHMP for IMBRUVICA in Previously Untreated CLL

April 29, 2016 8:15 AM EDT Send to a Friend
Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login